CliffBio
small molecule

ISONIAZID

ISONIAZID

Loss of exclusivity—loss of exclusivity
CompanyGenus Lifesciences Inc. →See this company's full patent-cliff portfolio

Drug detail

Brand nameISONIAZID
Active ingredientISONIAZID
Strength300MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
Marketing statusDISCN

More from Genus Lifesciences Inc.

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

ISONIAZID patent cliff — loss of exclusivity — | CliffBio